作者:
Coenen,E.A. [1]
;
Zwaan,C.M. [2]
;
Stary,J. [3]
;
Baruchel,A. [4]
;
DeHaas,V. [5]
;
Stam,R.W. [6]
;
Reinhardt,D. [7]
;
Kaspers,G.J.L. [8]
;
Arentsen-Peters,S.T.C.J.M. [9]
;
Meyer,C. [10]
;
Marschalek,R. ;
Nigro,L.L. ;
Dworzak,M. ;
Pieters,R. ;
VanDenHeuvel-Eibrink,M.M.
作者单位:
Institute of Pharmaceutical Biology, ZAFES, Diagnostic Center of Acute Leukemia (DCAL), Frankfurt
[1]
Pediatric Oncology/Hematology, Erasmus MC/Sophia Children's Hospital, Rotterdam, Netherlands
[2]
Pediatric Oncology/Hematology, VU University Medical Center, Amsterdam, Netherlands
[3]
Pediatric Hematology/Oncology, Charles University, University Hospital Motol, Prague, Czech Republic
[4]
AML-BFM Study Group, Hannover, Germany
[5]
Dutch Childhood Oncology Group (DCOG), The Hague, Netherlands
[6]
Center of Pediatric Hematology Oncology, Azienda Policlinico, Catania, Italy
[7]
Pediatric Oncology/Hematology, Erasmus MC/Sophia Children's Hospital, Rotterdam, Netherlands, Dutch
[8]
St Anna Children's Hospital, Children's Cancer Research Institute, Medical University of Vienna
[9]
Pediatric Hematology, H?pital Robert Debré AP-HP, University ParisDiderot, Paris, France
[10]
发布时间
2014-09-12